Verano Holdings: Analysts Expect $122 Million In EBITDA For Q2

Verano Holdings (CSE: VRNO) announced that they will be reporting their second quarter financials before the market opens on August 10.

Analysts have a consensus C$38.46 12-month price target on the company, via a total of 7 analysts, with 2 analysts having a strong buy rating, and 5 analysts have a buy rating. The street high comes from BTIG with a C$47 price target, and the lowest target comes in at C$19.70.

Six analysts have revenue estimates for the second quarter. The mean between all 6 is C$228.56 million; this number has been revised higher from C$205.51 million at the start of the year. The street high is C$247.37 million while the lowest sits at C$195.80 million.

Four analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 63.55%, with this number being revised slightly downwards from 65% at the start of the year. Street high goes to Beacon Securities with a 71% estimate and the lowest sits at 60%.

Onto EBITDA estimates, there are currently 6 analysts who have second quarter EBITDA estimates. The mean is currently C$122.58 million, with this number being higher than at the start of the year. Street high goes to Roth Capital with a C$248.46 million EBITDA estimate and the lowest being a C$82.10 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

BMO Gives Cameco Price Target A Lift To $33

On February 9th, Cameco (TSX: CCO) reported its full-year 2021 financial results. The company reported...

Monday, February 14, 2022, 02:59:00 PM

BMO: Signs Of Optimism Seen Among Precious Metals Investors

Over the last week, BMO has put out a set of notes updating their thoughts...

Tuesday, November 22, 2022, 07:27:00 AM

Coinbase: Analysts Expect $1.57 Billion In Q3 Revenues

Coinbase Global Inc (NASDAQ: COIN) is expected to report its third quarter 2021 financial results...

Tuesday, November 9, 2021, 11:28:00 AM

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM

Tilray: Canaccord Lowers Target On Expected Adult-Use Sales Slump, Revised Hexo Deal

Earlier this week, Tilray Brands (TSX: TLRY) announced an update to their strategic alliance with...

Friday, June 17, 2022, 10:49:29 AM